The unique bacterial enzyme, lysostaphin, discovered by Schindler and Schuhardt (1964) has a high degree of specificity for lysing staphylococci. These investigators found that lysostaphin lysed all staphylococcal cultures tested, including 54 strains of Staphylococcus aureus and 5 cultures of S. epidermidis. Cropp and Harrison (1964) tested 252 additional isolates, all of clinical origin, and found them highly susceptible to the lytic effect of lysostaphin. The strains tested were representative of three major S. aureus bacteriophage groups, including the phage-insensitive group, and varied in sensitivity to several clinically useful antibiotics. The present investigation was designed to evaluate quantitatively the antistaphylococcal activity of lysostaphin in comparison with other antibiotics used to treat infections caused by S. aureus.
MATERIALS AND METHODS
Clinical isolates. The 50 clinical isolates of S. aureus used in this study were Blair and Carr (1960) .
Minimal inhibitory concentration (MIC) test. The antistaphylococcal MIC for each antibiotic was determined by conventional tube-dilution methods, with Trypticase Soy broth (BBL). Each tube was inoculated with a diluted (106 organisms per milliliter) 24-hr broth culture of the isolate. Tubes were incubated at 37 C, and the MIC end point was determined after 18 hr according to the criterion of English and Gelwicks (1951) .
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